20 Ang A, Reddy MA, Shepstone L, Broadway DC. Long term effect of latanoprost on intraocular pressure in normal tension glaucoma. Br J Ophthalmol ,2004;88(5):630-634

21 Drance SM, Crichton A, Mills RP. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol ,1998;125(5):585-592

22 Klemm M, Zeitz O, Reuss J, Matthiessen ET, Richard G. Therapy of normal tension glaucoma: effect of brinzolamide on ocular haemodynamics. Klin Monatsbl Augenheilkd ,2003;220(5):330-333

23 Harris A, Migliardi R, Rechtman E, Cole CN, Yee AB, Garzozi HJ. Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. Eur J Ophthalmol ,2003;13(1):24-31

24 Harris A, Arend O, Chung HS, Kagemann L, Cantor L, Martin B. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients. Ophthalmology ,2000;107(3):430-434

25 Zeitz O, Matthiessen ET, Reuss J, Wiermann A, Wagenfeld L, Galambos P, Richard G, Klemm M. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide. BMC Ophthalmol , 2005;5:5(1):6

26王薇,沈念慈,王燕,张小兰,朱敏,朱力,吴磊.尼莫地平治疗正常眼压性青光眼23例.国际眼科杂志,2002;2(1):54-55

27 Yamamoto T, Niwa Y, Kawakami H, Kitaxawa Y. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma ,1998;7(5):301-305

28 Toriu N, Akaike A, Yasuyoshi H, Zhang S, Kashii S, Honda Y, Shimazawa M, Hara H. Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res ,2000;70(4):475-484

29 Toriu N, Sasaoka M, Shimazawa M, Sugiyama T, Hara H. Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits. J Ocul Pharmacol Ther ,2001;17(2):131-149

30 Quaranata L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology ,2003;110(2):359-362;discussion362-364

31 Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma ,1999;8(2):117-123

32徐联红.青光眼视神经的保护治疗.中国实用眼科杂志,2004;22(5):325-329

33吴凌,陈晓明.青光眼的视神经保护治疗.国际眼科杂志,2004;4(3):496-499

34 Wang NL, Sun XH, Li JZ, Wang JH, Chen XM, Lin D, Lü JH, Zhong YS, Zhang C, Guo WY. Neuroprotectiveeffects of erigeron breviscapus (vant) hand-mass on glaucoma—A multi-center clinical trial. Int J Ophthalmol(Guoji Yanke Zazhi) ,2004; 4(4):567-592

35郭文毅,孙兴怀,宋月莲,刘淳诗,茅凤英. 甲钴胺治疗青光眼性视野损害. 中国新药与临床杂志. 2000, 19(4):279-281

36邱远东,李丹. 复方樟柳碱注射液治疗青光眼性视神经萎缩. 中国临床康复.2004, 8(23):4853

上一页  [1] [2] [3] [4] [5]